Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

Radiofrequency Ablation Devices Market by Application (Cardiology, Oncology, and Pain Management), Product Type (Devices and Disposables) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

LI_16421
Pages: 157
Sep 2016 | 4130 Views
face gplus_n
Author's : Onkar Sumant
Tables: 50
Charts: 88
twit_n pr_n

Radiofrequency Ablation Devices Market Overview: 

Global Radiofrequency Ablation Devices Market was valued at $1,729 million in 2015, and is expected to reach $3,785 million by 2022, supported by a CAGR of 11.8% during the forecast period 2016-2022. Radiofrequency ablation (RFA) is a minimally invasive procedure, appropriate for patients with cardiac diseases (such as atrial fibrillation (AF), atrial flutter, cardiac arrhythmias), cancer and pain management. It has become a method of choice because of its high efficacy, ease of use, and safety. RFA is being increasingly used for the treatment of many diseases. such as cancer and cardiac arrhythmia.

The market growth is favored by the increase in prevalence of cardiovascular diseases, such as, atrial fibrillation, incidence of patients’ suffering from cancer and pain, and increase in demand for minimally-invasive procedures. The use of ultrasound ablation technology in RFAD is also augmenting the popularity of these devices. However, the market is limited by the high treatment cost, low awareness about the procedure, and availability of other treatments. It is estimated that the impact of drivers is expected to be higher than the restraints. Moreover, lucrative growth opportunities, such as expansion in emerging markets, untapped market in the developing regions, and technological advancements in RFA.

The report includes revenue generated from the sales of ablation devices that use radiofrequency energy for the process of ablation. Sales from the ablation devices that use other energy sources are not included in this report. The report does not include revenue generated from the service provided by doctors, nurses & consultancy, and hospital stay charges during the ablation treatment.

 

The report analyzes the radiofrequency ablation (RFA) devices market based on three categories: application, product type, and geography. Based on application, it is segmented into cardiology, oncology, and pain management. Based on product type, it is divided into devices and disposables. Based on geography, the market is analyzed as North America, Europe, Asia-Pacific, and LAMEA.

Based on application, the RFA devices market can be categorized into cardiology, oncology and pain management. There are two types of ablation catheters viz. conventional and irrigated-tip RFA catheters that can be used for the cardiology segment. The oncology segment is further segmented into spinal metastases, breast, colorectal, lung, prostate, liver, and kidney cancer. The pain management segment is further divided into neck, shoulder, upper back, lower back, knee pain, and other pain syndromes.

Based on product type, the RFA devices market can be segmented into devices and disposables. The device segment consists of RF generator, which is the main component of the RFA device. It generates electric current in the range of radiofrequency waves, and this current is transmitted through the insulated needle to deactivate the nerve and block the pain signal. The generator is connected to the needle electrodes and grounding pads by insulated wires. It uses an unmodified sinusoid that ranges in the frequency of 500 kHz to 6 GHz. The disposables used during radiofrequency ablation procedure include RF cannula, RF needles, RF single-use catheters, RF single-use probes, RF single-use electrodes, RF probes, and RF electrodes. 

Geographically, it is analyzed across North America (U.S., Canada, and Mexico); Europe (Germany, France, U.K., Italy, Spain, Russia, and Others); Asia-Pacific (Japan, China, India, Australia, South Korea, Taiwan, and Others); and LAMEA (Brazil, Turkey, Venezuela, Saudi Arabia, Republic of South Africa, and Others).

The radiofrequency ablation devices industry is growing due to the rise in incidence of cardiac diseases, such as atrial fibrillation (AF), atrial flutter, cardiac arrhythmias, and others. Hence, different mid-to-large size companies have augmented R&D investments in this market. In addition, smaller companies have shifted their focus on increased R&D activities in the RFAD market, resulting in large number of product developments (approvals & launches), and in turn contributing to the market growth.

Acquisition was another key strategy adopted by larger companies to acquire smaller and emerging companies, owing to the presence of large number of small- to mid-sized companies manufacturing RF devices. This is evident from the strategic acquisition of Cosman Medical, Inc., a mass manufacturer of radiofrequency ablation systems, by Boston Scientific Corporation in July 2016. The Cosman Medical team and products will become a part of the Boston Scientific Neuromodulation business, which offers a wide range of spinal cord stimulator (SCS) systems to treat patients with chronic pain, and deep brain stimulation systems to treat Parkinson's disease, dystonia, and essential tremor.

 

The Venezuelan radiofrequency ablation devices industry is estimated to reach $3.3 million by 2022 growing at a CAGR of 11.4% over the next seven years. 

The key players profiled in this report include Halyard Health, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic Plc, Boston Scientific Corporation, C. R. Bard, Inc., AngioDynamics, Inc., Hologic, Inc., AtriCure, Inc., and Johnson & Johnson. Other players in the RFAD industry include Baylis Medical, Arthrex, Inc., inomed Medizintechnik GmbH, Sutter Medizintechnik GmbH, Bramsys Indústria e Comércio Ltda, ENDO-FLEX GmbH, Epimed International, and sfm medical devices GmbH.

RADIOFREQUENCY ABLATION DEVICES MARKET KEY BENEFITS 

  • The global radiofrequency ablation devices market report provides an extensive analysis of the current market trends and future estimations through 20142022.

  • The market scenario is comprehensively analyzed with respect to the application and product type.

  • Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities.

  • Recent developments and key manufacturers are listed to understand the competitive market scenario.

  • In-depth analysis based on geography provides an understanding of the regional market, which assists in strategic business planning.

RADIOFREQUENCY ABLATION DEVICES MARKET KEY SEGMENTS:

The global radiofrequency ablation devices market segmentation is illustrated as follows:

By Application

  • Cardiology

    • Conventional RF Ablation Catheters

    • Irrigated Tip RF Ablation Catheters

  • Oncology

    • Breast Cancer

    • Colorectal Cancer

    • Lung Cancer

    • Prostate Cancer

    • Liver Cancer

    • Kidney Cancer

    • Spinal Metastases

    • Other Cancers

  • Pain management

    • Neck Pain

    • Shoulder Pain

    • Upper Back Pain

    • Lower Back Pain

    • Knee Pain

    • Other Pain Syndromes

By Product Type

  • Devices

  • Disposables

By Geography 

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • U.K.

    • Italy

    • Spain

    • Russia

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • Australia

    • India

    • South Korea

    • Taiwan

    • Rest of Asia-Pacific

  • LAMEA

    • Brazil

    • Turkey

    • Venezuela

    • Saudi Arabia

    • Republic of South Africa

    • Rest of LAMEA

 

 

 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO Perspective
2.2 Market beyond: what to expect by 2027 ($million)

2.2.1 Moderate Growth Scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Government regulations

3.3.1 U.S. FDA
3.3.2 Europe CE Mark
3.3.3 Ministry of Health, Labour and Welfare (MHLW)

3.4 Reimbursement scenarios
3.5 Porter's five forces analysis

3.5.1 Low bargaining power of suppliers
3.5.2 Moderate bargaining power of buyers
3.5.3 Low threat of new entrants
3.5.4 Low threat of substitutes
3.5.5 Moderate competitive rivalry

3.6 Clinical trials
3.7 Patent analysis

3.7.1 China: Patent Analysis by Market Participants
3.7.2 The U.S.: Patent Analysis by Market Participants
3.7.3 Europe: patent analysis, by market participant
3.7.4 Canada: patent analysis, by market participant
3.7.5 Others: Patent Analysis, by Market Participant

3.8 Top player positioning, 2015
3.9 Top impacting factors

3.9.1 Drivers

3.9.1.1 Rise in the prevalence of cancer and cardiac diseases
3.9.1.2 Increase in the number of patients suffering from pain
3.9.1.3 High efficacy and short duration of the procedure

3.9.2 Restrains

3.9.2.1 High cost of treatment
3.9.2.2 Limited awareness
3.9.2.3 Availability of other treatments

3.9.3 Opportunities

3.9.3.1 Lucrative opportunities in emerging markets
3.9.3.2 Untapped RFA market opportunity
3.9.3.3 Recent advancements

Chapter: 4 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION

4.1 Overview

4.1.1 Market size and forecast

4.2 Cardiology

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Irrigated-tip RF ablation catheters
4.2.5 Conventional RF ablation catheters

4.3 Oncology

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Breast cancer
4.3.5 Colorectal cancer
4.3.6 Lung cancer
4.3.7 Prostate cancer
4.3.8 Liver cancer
4.3.9 Kidney cancer
4.3.10 Spinal metastases
4.3.11 Other cancers

4.4 Pain management

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Neck pain
4.4.5 Shoulder pain
4.4.6 Upper back pain
4.4.7 Lower back pain
4.4.8 Knee pain
4.4.9 Other pain syndromes

Chapter: 5 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE

5.1 Overview

5.1.1 Market size and forecast

5.2 Devices

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast

5.3 Disposables

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

Chapter: 6 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY GEOGRAPHY

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size & forecast
6.2.5 Canada market size & forecast
6.2.6 Mexico market size & forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size & forecast
6.3.5 France market size & forecast
6.3.6 U.K. market size & forecast
6.3.7 Italy market size & forecast
6.3.8 Spain market size & forecast
6.3.9 Russia market size & forecast
6.3.10 Rest of Europe market size & forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan market size & forecast
6.4.5 China market size & forecast
6.4.6 Australia market size & forecast
6.4.7 India market size & forecast
6.4.8 South Korea market size & forecast
6.4.9 Taiwan market size & forecast
6.4.10 Rest of Asia Pacific market size & forecast

6.5 Latin America, Middle East, Africa (LAMEA)

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil market size & forecast
6.5.5 Turkey market size & forecast
6.5.6 Venezuela market size & forecast
6.5.7 Saudi Arabia market size & forecast
6.5.8 Republic of South Africa market size & forecast
6.5.9 Rest of LAMEA market size & forecast

Chapter: 7 COMPANY PROFILES

7.1 Halyard Health, Inc.

7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance

7.2 Stryker Corporation

7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & developments

7.3 St. Jude Medical, Inc.

7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & developments

7.4 Medtronic PLC

7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments

7.5 Boston Scientific Corporation

7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments

7.6 C. R. Bard, Inc.

7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategic moves & developments

7.7 AngioDynamics, Inc.

7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments

7.8 Hologic, Inc.

7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments

7.9 AtriCure, Inc.

7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments

7.10 Johnson and Johnson

7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key Strategic moves & developments

*Other players in the value chain include

  • Baylis Medical
  • Arthrex, Inc.
  • inomed Medizintechnik GmbH
  • Sutter Medizintechnik GmbH
  • Bramsys Indstria e Comrcio Ltda
  • ENDO-FLEX GmbH
  • Epimed International
  • sfm medical devices GmbH

*Profiles of these players are not included. The same will be included on request.

List of Figures

FIG. 1 TOP INVESTMENT POCKETS: WORLD RADIOFREQUECNY ABLATION DEVICES MARKET, BY APPLICATION
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 PATENTS REGISTERED/APPROVED WORLDWIDE, 20132016
FIG. 6 CHINA: PATENT ANALYSIS BY MARKET PARTICIPANTS, 20132016
FIG. 7 U.S.: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016
FIG. 8 EUROPE: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016
FIG. 9 CANADA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2013 THROUGH 2016
FIG. 10 OTHERS: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016
FIG. 11 TOP PLAYER POSITIONING, 2015
FIG. 12 TOP IMPACTING FACTORS
FIG. 13 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 2015
FIG. 14 IRRIGATED-TIP RF ABLATION CATHETERS MARKET, 20142022 ($MILLION)
FIG. 15 CONVENTIONAL RF ABLATION CATHETERS MARKET, 20142022 ($MILLION)
FIG. 16 BREAST CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 17 COLORECTAL CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 18 LUNG CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 19 PROSTATE CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 20 LIVER CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 21 KIDNEY CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 22 SPINAL METASTASES RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 23 OTHER CANCERS RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 24 NECK PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 25 SHOULDER PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 26 UPPER BACK PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 27 LOWER BACK PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 28 KNEE PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 29 OTHER PAIN SYNDROMES RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 30 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2015
FIG. 31 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY GEOGRAPHY, 2015
FIG. 32 NORTH AMERICA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015
FIG. 33 U.S. RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 34 CANADA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 35 MEXICO RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 36 EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015
FIG. 37 GERMANY RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 38 FRANCE RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 39 U.K. RADIOFREQUENCY ABLATION DEVICES MARKET, 2015
FIG. 40 ITALY RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 41 SPAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 42 RUSSIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 43 REST OF EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 44 ASIA-PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015
FIG. 45 JAPAN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 46 CHINA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 47 AUSTRALIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 48 INDIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 49 SOUTH KOREA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 50 TAIWAN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 51 REST OF ASIA PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 52 LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015
FIG. 53 BRAZIL RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 54 TURKEY RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 55 VENEZUELA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 56 SAUDI ARABIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 57 REPUBLIC OF SOUTH AFRICA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 58 REST OF LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)
FIG. 59 HALYARD: REVENUE, BY YEAR ($MILLION)
FIG. 60 HALYARD: REVENUE, BY SEGMENT, 2015 (%)
FIG. 61 HALYARD: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 62 STRYKER: REVENUE, BY YEAR ($MILLION)
FIG. 63 STRYKER: REVENUE, BY SEGMENT, 2015 (%)
FIG. 64 STRYKER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 65 ST. JUDE MEDICAL: REVENUE, BY YEAR ($MILLION)
FIG. 66 ST. JUDE MEDICAL: REVENUE, BY PRODUCT, 2015 (%)
FIG. 67 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 68 MEDTRONIC: REVENUE, BY YEAR ($MILLION)
FIG. 69 MEDTRONIC: REVENUE, BY SEGMENT, 2016 (%)
FIG. 70 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 71 BOSTON: REVENUE, BY YEAR ($MILLION)
FIG. 72 BOSTON: REVENUE, BY SEGMENT, 2015 (%)
FIG. 73 BOSTON: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 74 BARD: REVENUE, BY YEAR ($MILLION)
FIG. 75 BARD: REVENUE, BY SEGMENT, 2015 (%)
FIG. 76 BARD: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 77 ANGIODYNAMICS: REVENUE, BY YEAR ($MILLION)
FIG. 78 ANGIODYNAMICS: REVENUE, BY SEGMENT, 2016 (%)
FIG. 79 ANGIODYNAMICS: REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 80 HOLOGIC: REVENUE, BY YEAR ($MILLION)
FIG. 81 HOLOGIC: REVENUE, BY GEOGRAPHY (%)
FIG. 82 HOLOGIC: REVENUE, BY PRODUCT (%)
FIG. 83 ATRICURE: REVENUE, BY YEAR ($MILLION)
FIG. 84 ATRICURE: REVENUE, BY PRODUCT, 2015 (%)
FIG. 85 ATRICURE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 86 J&J: REVENUE, BY YEAR ($MILLION)
FIG. 87 J&J: REVENUE, BY SEGMENT, 2015 (%)
FIG. 88 J&J: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 RADIOFREQUENCY ABLATION DEVICES MARKET, MODERATE GROWTH SCENARIO, BY GEOGRAPHY, 20222027 ($MILLION)
TABLE 2 RADIOFREQUENCY ABLATION DEVICES MARKET, RAPID GROWTH SCENARIO, BY GEOGRAPHY, 20222027 ($MILLION)
TABLE 3 RADIOFREQUENCY ABLATION DEVICES MARKET, DIMINISHING GROWTH SCENARIO, BY GEOGRAPHY, 20222027 ($MILLION)
TABLE 4 CLINICAL TRIALS, RADIOFREQUENCY ABLATION DEVICES MARKET, 20132016
TABLE 5 PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE, AND JAPAN (20132016)
TABLE 6 CHINA: PATENT ANALYSIS BY MARKET PARTICIPANTS, 20132016
TABLE 7 U.S.: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016
TABLE 8 EUROPE: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016
TABLE 9 CANADA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016
TABLE 10 OTHERS: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016
TABLE 11 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)
TABLE 12 WORLD CARDIOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 13 WORLD CARDIOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 14 WORLD ONCOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 15 WORLD ONCLOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 16 WORLD PAIN MANAGEMENT RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 17 WORLD PAIN MANAGEMENT RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 18 KEY SPECIFICATIONS OF DISPOSABLES USED DURING RADIOFREQUENCY ABLATION PROCEDURE
TABLE 19 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 20 WORLD RADIOFREQUENCY ABLATION MARKET FOR DEVICES, BY REGION, 20142022 ($MILLION)
TABLE 21 WORLD RADIOFREQUENCY ABLATION MARKET FOR DISPOSABLES, BY REGION, 20142022 ($MILLION)
TABLE 22 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 23 NORTH AMERICA RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)
TABLE 24 NORTH AMERICA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 25 EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)
TABLE 26 EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 27 ASIA-PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)
TABLE 28 ASIA-PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 29 LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)
TABLE 30 LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 31 HALYARD - COMPANY SNAPSHOT
TABLE 32 HALYARD - OPERATING SEGMENTS
TABLE 33 STRYKER - COMPANY SNAPSHOT
TABLE 34 STRYKER - OPERATING SEGMENTS
TABLE 35 ST. JUDE MEDICAL - COMPANY SNAPSHOT
TABLE 36 ST. JUDE MEDICAL - OPERATING SEGMENTS
TABLE 37 MEDTRONIC - COMPANY SNAPSHOT
TABLE 38 MEDTRONIC OPERATING SEGMENTS
TABLE 39 BOSTON - COMPANY SNAPSHOT
TABLE 40 BOSTON OPERATING SEGMENTS
TABLE 41 BARD COMPANY SNAPSHOT
TABLE 42 BARD - OPERATING SEGMENTS
TABLE 43 ANGIODYNAMICS - COMPANY SNAPSHOT
TABLE 44 ANGIODYNAMICS - OPERATING SEGMENTS
TABLE 45 HOLOGIC - COMPANY SNAPSHOT
TABLE 46 HOLOGIC - OPERATING SEGMENTS
TABLE 47 ATRICURE - COMPANY SNAPSHOT
TABLE 48 ATRICURE - OPERATING SEGMENTS
TABLE 49 J&J - COMPANY SNAPSHOT
TABLE 50 J&J - OPERATING SEGMENTS

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Radiofrequency Ablation Devices Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts